AnaptysBio, Inc. (FRA:AN6)
35.80
-0.20 (-0.56%)
At close: Nov 28, 2025
AnaptysBio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 109.83 | 123.08 | 35.97 | 71.31 | 495.73 | 250.46 | Upgrade |
Short-Term Investments | 139.12 | 262.29 | 354.94 | 369.93 | 52.37 | 143.2 | Upgrade |
Cash & Short-Term Investments | 248.96 | 385.37 | 390.9 | 441.24 | 548.1 | 393.65 | Upgrade |
Cash Growth | -42.12% | -1.42% | -11.41% | -19.50% | 39.23% | 5.19% | Upgrade |
Accounts Receivable | 75.69 | 40.77 | 6.85 | 1.42 | 0.88 | - | Upgrade |
Receivables | 75.69 | 40.77 | 6.85 | 1.42 | 0.88 | - | Upgrade |
Prepaid Expenses | 6.01 | 5.74 | 9.08 | 4.55 | 4.9 | 2.91 | Upgrade |
Total Current Assets | 330.65 | 431.88 | 406.84 | 447.21 | 553.88 | 396.56 | Upgrade |
Property, Plant & Equipment | 14.49 | 16.23 | 18.27 | 19.99 | 21.84 | 2.13 | Upgrade |
Long-Term Investments | 7.7 | 35.47 | 27.03 | 142.94 | 67.1 | 17.55 | Upgrade |
Other Long-Term Assets | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.32 | Upgrade |
Total Assets | 353.1 | 483.83 | 452.39 | 610.38 | 643.07 | 416.55 | Upgrade |
Accounts Payable | 2.89 | 4 | 4.7 | 2.78 | 1.74 | 4.22 | Upgrade |
Accrued Expenses | 32.62 | 39.5 | 30.51 | 21.63 | 12.85 | 15.26 | Upgrade |
Current Portion of Leases | 2.04 | 1.93 | 1.78 | 1.64 | 1.51 | 0.34 | Upgrade |
Other Current Liabilities | 0.55 | - | 0.46 | - | - | - | Upgrade |
Total Current Liabilities | 38.1 | 45.43 | 37.44 | 26.05 | 16.1 | 19.82 | Upgrade |
Long-Term Debt | 331.84 | 353.43 | 310.81 | 304.41 | 251.09 | - | Upgrade |
Long-Term Leases | 12.57 | 14.11 | 16.04 | 17.81 | 19.45 | - | Upgrade |
Total Liabilities | 382.51 | 412.97 | 364.29 | 348.28 | 286.64 | 19.82 | Upgrade |
Common Stock | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade |
Additional Paid-In Capital | 792.68 | 829.86 | 702.97 | 717.8 | 678.58 | 660.67 | Upgrade |
Retained Earnings | -822.17 | -759.33 | -614.1 | -450.48 | -321.75 | -263.96 | Upgrade |
Comprehensive Income & Other | 0.05 | 0.31 | -0.8 | -5.25 | -0.42 | -0 | Upgrade |
Total Common Equity | -29.42 | 70.87 | 88.1 | 262.1 | 356.43 | 396.73 | Upgrade |
Shareholders' Equity | -29.42 | 70.87 | 88.1 | 262.1 | 356.43 | 396.73 | Upgrade |
Total Liabilities & Equity | 353.1 | 483.83 | 452.39 | 610.38 | 643.07 | 416.55 | Upgrade |
Total Debt | 346.45 | 369.46 | 328.62 | 323.86 | 272.05 | 0.34 | Upgrade |
Net Cash (Debt) | -97.49 | 15.91 | 62.28 | 117.38 | 276.05 | 393.31 | Upgrade |
Net Cash Growth | - | -74.45% | -46.94% | -57.48% | -29.81% | 5.92% | Upgrade |
Net Cash Per Share | -3.31 | 0.56 | 2.31 | 4.17 | 10.06 | 14.41 | Upgrade |
Filing Date Shares Outstanding | 27.69 | 30.67 | 26.76 | 27.93 | 27.67 | 27.37 | Upgrade |
Total Common Shares Outstanding | 27.58 | 30.47 | 26.6 | 28.51 | 27.65 | 27.36 | Upgrade |
Working Capital | 292.55 | 386.45 | 369.39 | 421.15 | 537.78 | 376.74 | Upgrade |
Book Value Per Share | -1.07 | 2.33 | 3.31 | 9.19 | 12.89 | 14.50 | Upgrade |
Tangible Book Value | -29.42 | 70.87 | 88.1 | 262.1 | 356.43 | 396.73 | Upgrade |
Tangible Book Value Per Share | -1.07 | 2.33 | 3.31 | 9.19 | 12.89 | 14.50 | Upgrade |
Machinery | 8.31 | 8.25 | 8.11 | 7.46 | 7 | 6.2 | Upgrade |
Leasehold Improvements | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.53 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.